- Home
- LSPD vs TARS Comparison
LSPD vs TARS Comparison
Compare LSPD & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSPD
- TARS
- Stock Information
- Founded
- LSPD 2005
- TARS 2016
- Country
- LSPD Canada
- TARS United States
- Employees
- LSPD N/A
- TARS N/A
- Industry
- LSPD
- TARS Medicinal Chemicals and Botanical Products
- Sector
- LSPD
- TARS Health Care
- Exchange
- LSPD Nasdaq
- TARS Nasdaq
- Market Cap
- LSPD 1.6B
- TARS 1.7B
- IPO Year
- LSPD 2020
- TARS 2020
- Fundamental
- Price
- LSPD $11.61
- TARS $39.18
- Analyst Decision
- LSPD Buy
- TARS Strong Buy
- Analyst Count
- LSPD 13
- TARS 7
- Target Price
- LSPD $13.42
- TARS $67.14
- AVG Volume (30 Days)
- LSPD 568.0K
- TARS 601.2K
- Earning Date
- LSPD 07-31-2025
- TARS 08-07-2025
- Dividend Yield
- LSPD N/A
- TARS N/A
- EPS Growth
- LSPD N/A
- TARS N/A
- EPS
- LSPD N/A
- TARS N/A
- Revenue
- LSPD $1,076,826,000.00
- TARS $233,674,000.00
- Revenue This Year
- LSPD $13.02
- TARS $122.94
- Revenue Next Year
- LSPD $16.19
- TARS $44.14
- P/E Ratio
- LSPD N/A
- TARS N/A
- Revenue Growth
- LSPD 18.43
- TARS 449.03
- 52 Week Low
- LSPD $7.34
- TARS $20.08
- 52 Week High
- LSPD $18.96
- TARS $57.28
- Technical
- Relative Strength Index (RSI)
- LSPD 53.93
- TARS 39.78
- Support Level
- LSPD $11.46
- TARS $38.52
- Resistance Level
- LSPD $11.92
- TARS $41.72
- Average True Range (ATR)
- LSPD 0.33
- TARS 1.51
- MACD
- LSPD -0.02
- TARS 0.13
- Stochastic Oscillator
- LSPD 74.06
- TARS 19.08
About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares
Lightspeed Commerce Inc provides an omni-channel commerce-enabling SaaS platform. Its software platform provides customers with the functionality it needs to engage with consumers, manage their operations, accept payments, and grow their businesses. The company sells its platform through a direct sales force in the United States, Canada, United Kingdom, Australia, and other countries. It derives a majority of its revenue from the United States.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.